PCI BIOTECH HOLDING ASA: årsregnskap 2024 vs 2023
Shrank 100% on revenue, slipped into loss, fresh owner capital
approved 2025-05-22; registry 2025-06-05; journal 2025 465794
Summary
What changed
Comparing Årsregnskap 2024 with 2023 for PCI BIOTECH HOLDING ASA. Revenue 2.99m NOK → 0 NOK (-100.0%). Net result +435.0k NOK → -35.3k NOK. Equity 78.42m NOK → 43.99m NOK.
On the constructive side: operating result improved; cash rose; owners injected capital. Pressures included: revenue fell; fell into a net loss; equity eroded.
Also worth watching: book investments changed. All figures are taken from the published annual accounts for PCI BIOTECH HOLDING ASA.
At a glance
Scorecard
What improved
-
↑
Operating result improved
Operating result -4.64m NOK → -4.23m NOK. Calculated
-
↑
Cash rose
Bank deposits 56.0k NOK → 540.0k NOK (+864.3% YoY). Calculated
-
↑
Owners injected capital
Paid-in equity rose 1.12m NOK → 43.99m NOK (+42.87m NOK). Reported fact
What deteriorated
-
↓
Revenue fell
Operating income / revenue moved from 2.99m NOK to 0 NOK (-100.0% YoY). Calculated
-
↓
Fell into a net loss
Net result flipped from 435.0k NOK profit to a loss of 35.3k NOK. Calculated
-
↓
Equity eroded
Book equity 78.42m NOK → 43.99m NOK (equity ratio 98.9% → 95.8%). Calculated
Things to notice
-
·
Book investments changed
Investment / intangible book value 75.66m NOK → 45.28m NOK. Reported fact